华康生物医学(股票代码:08622)于2026年4月1日发布3月股份变动月报表。报告期为2026年3月1日至3月31日,公司注册股本及已发行股本均未发生变化。
报告显示,公司于月末的法定注册股本维持在1,000,000,000股,面值每股0.01港元,总计10,000,000港元。已发行普通股股份总数亦保持515,472,000股,无库藏股或新增发行、回购与注销情况。公司亦确认当月无任何股份期权、权证及可换股票据的授予与行使事项。
截至本月末,华康生物医学股本维持稳定,公司声明其已遵守香港联交所《上市规则》及相关法律法规,由公司秘书周丽麒签署本次公告。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.